18.2
Immix Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
14.9
FY23:
19.8
FY24:
20.2
FY25:
101
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.01
FY23:
0.14
FY24:
2.75
FY25:
3.60
Total assets
Change from FY21 to FY25
millions USD
FY21:
18.2
FY22:
14.9
FY23:
19.9
FY24:
22.9
FY25:
105
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.20
FY22:
1.27
FY23:
3.72
FY24:
8.69
FY25:
10.1
(negative)
millions USD
FY21:
0
FY22:
0.48
FY23:
0
FY24:
1.01
FY25:
0.93
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.0
FY22:
13.2
FY23:
16.4
FY24:
13.3
FY25:
93.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
18.2
FY22:
14.9
FY23:
20.1
FY24:
22.9
FY25:
105
All amounts in millions USD